Phillip Doerfler

Associate Investigator at the Versiti Blood Research Institute and Assistant Professor at the Medical College of Wisconsin



Department of Hematopoiesis and Immunology

Versiti Blood Research Institute



Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease.


Journal article


Phillip A. Doerfler, A. G. Todd, N. Clément, D. Falk, Sushrusha Nayak, R. Herzog, B. Byrne
Human Gene Therapy, 2016

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Doerfler, P. A., Todd, A. G., Clément, N., Falk, D., Nayak, S., Herzog, R., & Byrne, B. (2016). Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease. Human Gene Therapy.


Chicago/Turabian   Click to copy
Doerfler, Phillip A., A. G. Todd, N. Clément, D. Falk, Sushrusha Nayak, R. Herzog, and B. Byrne. “Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease.” Human Gene Therapy (2016).


MLA   Click to copy
Doerfler, Phillip A., et al. “Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease.” Human Gene Therapy, 2016.


BibTeX   Click to copy

@article{phillip2016a,
  title = {Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease.},
  year = {2016},
  journal = {Human Gene Therapy},
  author = {Doerfler, Phillip A. and Todd, A. G. and Clément, N. and Falk, D. and Nayak, Sushrusha and Herzog, R. and Byrne, B.}
}


Share

Tools
Translate to